← FDA Drug Approvals (Drugs@FDA)

NDA209618

NDA · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2017-08-18

Drug application

FDA Application #

NDA209618

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

AUROBINDO PHARMA LTD

First approval

2017-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown